210 related articles for article (PubMed ID: 6133543)
1. Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.
Boehringer K; Weidmann P; Link L; Bianchetti MG; Schiffl H; Reubi FC
Br J Clin Pharmacol; 1983 Feb; 15(2):181-8. PubMed ID: 6133543
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
Steiner JA; Clancy A; Manghani KK; James IM
Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
[TBL] [Abstract][Full Text] [Related]
6. Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions.
Andersen GS; Hartling OJ; Hein HO; Leth A
Dan Med Bull; 1985 Oct; 32(5):280-3. PubMed ID: 2865088
[TBL] [Abstract][Full Text] [Related]
7. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
Pitcher DW; Curry PV; Trounce JR
Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of prizidilol and propranolol on renal haemodynamics at rest and during exercise.
Malini PL; Strocchi E; Ambrosioni E
Br J Clin Pharmacol; 1984 Mar; 17(3):251-5. PubMed ID: 6712858
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of the stereoisomers of prizidilol: their use in analysis of reflex tachycardia and blood pressure control in normotensive cats, rats, and dogs.
Owen DA; Eden RJ; Lamb MS; Taylor EM
J Cardiovasc Pharmacol; 1986; 8(4):743-8. PubMed ID: 2427813
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prizidilol, a new antihypertensive drug with combined arteriolar vasodilator and beta-adrenoceptor blocking actions, with hydralazine and propranolol in conscious dogs with chronic atrioventricular block.
Boucher M; Dubray C; Duchêne-Marullaz P
J Cardiovasc Pharmacol; 1983; 5(5):712-6. PubMed ID: 6195455
[TBL] [Abstract][Full Text] [Related]
11. Renal function studies with propildazine alone and in combination with propranolol in dogs.
Dorigotti L; Semeraro C
Eur J Pharmacol; 1980 Oct; 67(2-3):275-82. PubMed ID: 7461034
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
[TBL] [Abstract][Full Text] [Related]
13. Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise.
Lund-Johansen P; Omvik P
J Cardiovasc Pharmacol; 1982; 4(6):1012-7. PubMed ID: 6185765
[TBL] [Abstract][Full Text] [Related]
14. Renal function studies with cadralazine in conscious dogs: a comparison with hydralazine.
Ferni G; Bonardi G; Lombroso M; Semeraro C; Dorigotti L
Pharmacol Res; 1989; 21(2):211-22. PubMed ID: 2664751
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.
Edmondstone WM; Waller JF; Manghani KK; Hill PL; Bell AJ; Denison DM
Br J Clin Pharmacol; 1983 Dec; 16(6):591-8. PubMed ID: 6140939
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology and pharmacokinetics of prizidilol in hypertensive patients.
Chaignon M; Decourt S; Guelpa G; Rocher I; Flouvat B; Guédon J
J Cardiovasc Pharmacol; 1983; 5(6):1068-73. PubMed ID: 6196556
[TBL] [Abstract][Full Text] [Related]
17. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
Pedrinelli R; Abdel-Haq B; Magagna A; Leto di Priolo S; Simonini N; Salvetti A
Int J Clin Pharmacol Res; 1984; 4(2):155-63. PubMed ID: 6147320
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effect of prizidilol.
Andrén L; Hansson L; Svensson A
J Cardiovasc Pharmacol; 1983; 5(5):898-900. PubMed ID: 6195483
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
